secwatch.observer — SEC 8-K summary
======================================

Issuer:     HENRY SCHEIN INC (HSIC)
CIK:        0001000228
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001000228-23-000024
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Schein Q1 revenue down 3.8% to $3.1B; non-GAAP EPS $1.21 vs $1.44; lowers 2023 guidance to $5.18-$5.35
--------------------------------------------------------------------------------

- GAAP diluted EPS $0.91 vs $1.30; non-GAAP diluted EPS $1.21 vs $1.44.
- Net sales $3.1B, down 3.8% YoY; internal sales grew 6.3% ex-PPE and COVID test kits.
- Global Medical sales $1.0B down 17.2% (up 4.2% ex-PPE/COVID test kits); Dental $1.9B up 3.8%.
- 2023 non-GAAP EPS guidance cut to $5.18-$5.35 from prior $5.38; includes $0.05-$0.10 Biotech Dental dilution.
- Repurchased 1.2M shares for $100M in Q1; $415M remains authorized for buybacks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/0001000228-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/hsic-20230509.htm
  HTML page:      https://secwatch.observer/filing/0001000228-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer